Globus Medical
GMED
381 hedge funds and large institutions have $4.84B invested in Globus Medical in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 147 increasing their positions, 111 reducing their positions, and 57 closing their positions.
3,231% more call options, than puts
Call options by funds: $27.4M | Put options by funds: $822K
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
32% more repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 111
14% more capital invested
Capital invested by funds: $4.23B → $4.84B (+$610M)
8.33% more ownership
Funds ownership: 96.14% → 104.47% (+8.3%)
2% less funds holding
Funds holding: 389 → 381 (-8)
12% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 57
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$59.2M |
| 2 |
TAL
TIG Advisors LLC
New York
|
+$55.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$53.2M |
| 4 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$45.6M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$42.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$47.5M |
| 2 |
Barclays
London,
United Kingdom
|
-$46.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$44.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$29.3M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$19.5M |
GMED Hedge Fund Activity: Q2 2023 in Review
381 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2023, worth a combined $4.84B — up 14% from $4.23B a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of GMED and 50 opened new positions — a net loss of 7 holders — while 111 trimmed existing stakes and 147 added.
The largest buyer was Millennium Management, adding an estimated $59.2M. The largest seller was Citadel Advisors, cutting an estimated $47.5M.
- 381 institutional investors held Globus Medical (GMED) as of Q2 2023, down from 389 in Q1 2023.
- Funds reported $4.84B of Globus Medical stock for Q2 2023, up 14% quarter-over-quarter.
- 50 funds opened new Globus Medical positions in Q2 2023 and 57 closed out, a net change of -7 holders.
- The largest Globus Medical buyer in Q2 2023 was Millennium Management, an estimated $59.2M added.
- The largest Globus Medical seller in Q2 2023 was Citadel Advisors, an estimated $47.5M sold.
Based on aggregated 13F filings for Q2 2023.